pSivida inks deal to acquire Control Delivery Systems
Australia's pSivida has inked a deal to buy Control Delivery Systems, a drug delivery company. CDS stockholders will wind up with 40 percent of the shares of a combined company, giving the deal a $104 million value. The Australian company also gains a new operating hub in the biotech-rich Boston area.
- read this report from Small Times for more
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
